Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	532.54	615.1	905.45	1,431	1,895	94.24
Short-Term Investments	-	13.41	2.09	65.63	367.39	316.65
Cash & Short-Term Investments	532.54	628.5	907.55	1,497	2,263	410.89
Cash Growth	-27.30%	-30.75%	-39.37%	-33.84%	450.69%	201.56%
Accounts Receivable	173.66	149.61	151.71	134.59	110.75	89.73
Other Receivables	-	1.18	0.1	0.11	2.23	81.56
Receivables	178.98	150.79	151.81	138.2	112.98	171.29
Inventory	65.81	69.02	130.32	123.21	68.02	58.12
Restricted Cash	0.51	0.12	19.82	7.8	29.9	4.01
Other Current Assets	28.46	35.67	49.27	54.79	50.06	62.48
Total Current Assets	806.29	884.1	1,259	1,821	2,524	706.79
Property, Plant & Equipment	206.15	144.2	300.03	406.45	111.48	89.31
Long-Term Investments	0.25	0.34	0.69	0.91	1.42	40.16
Other Intangible Assets	0.72	0.96	1.99	5.15	3.46	0.34
Other Long-Term Assets	9.98	5.09	20.89	45.14	23.02	10.95
Total Assets	1,023	1,040	1,587	2,279	2,663	847.56
Accounts Payable	25.87	18.06	50.95	63.08	35.48	12.35
Accrued Expenses	86.3	65.37	104.23	107.03	71.89	44.6
Short-Term Debt	-	-	-	2.37	7.37	2.37
Current Portion of Long-Term Debt	-	-	-	-	34.7	37.13
Current Portion of Leases	26.92	8.63	37.24	35	4.82	4.89
Current Income Taxes Payable	-	20.62	11.03	7.69	6.99	6.38
Current Unearned Revenue	119.35	130.54	147.63	142.87	74.4	49.54
Other Current Liabilities	1.2	20.14	60.38	14.14	5.89	7.18
Total Current Liabilities	259.64	263.36	411.45	372.18	241.53	164.44
Long-Term Debt	-	-	-	-	-	18.27
Long-Term Leases	80.99	3.69	13.55	49.32	-	4.82
Long-Term Unearned Revenue	-	-	-	-	0.26	0.99
Other Long-Term Liabilities	4.91	4.54	4.12	11.78	0.23	-
Total Liabilities	345.54	271.59	429.13	433.28	242.02	188.52
Common Stock	0.14	0.14	0.14	0.14	0.14	0.03
Additional Paid-In Capital	4,987	4,849	4,583	4,281	4,007	45.64
Retained Earnings	-4,083	-3,854	-3,200	-2,229	-1,418	-946.46
Treasury Stock	-65.9	-65.9	-58.92	-	-	-
Comprehensive Income & Other	-160	-161.53	-165.72	-207.07	-167.59	9.3
Total Common Equity	677.85	768.41	1,158	1,845	2,421	-891.49
Shareholders' Equity	677.85	768.41	1,158	1,845	2,421	659.04
Total Liabilities & Equity	1,023	1,040	1,587	2,279	2,663	847.56
Total Debt	107.91	12.32	50.79	86.69	46.88	67.47
Net Cash (Debt)	424.63	616.18	856.76	1,410	2,216	343.41
Net Cash Growth	-39.51%	-28.08%	-39.25%	-36.35%	545.24%	-
Net Cash Per Share	41.44	60.18	82.45	135.33	322.84	146.23
Filing Date Shares Outstanding	10.26	10.26	10.27	10.52	10.45	2.5
Total Common Shares Outstanding	10.26	10.24	10.26	10.51	10.48	2.5
Working Capital	546.65	620.73	847.31	1,449	2,282	542.35
Book Value Per Share	66.07	75.01	112.85	175.56	231.05	-356.15
Tangible Book Value	677.12	767.45	1,156	1,840	2,418	-891.84
Tangible Book Value Per Share	66.00	74.92	112.66	175.07	230.72	-356.28
Machinery	-	348.07	339.09	297.89	180.54	138.78
Construction In Progress	-	0.55	2.66	27.56	1.09	0.67
Leasehold Improvements	-	187.39	187.38	161.04	30.67	24.65

Source: S&P Capital IQ. Standard template. Financial Sources.